Company | Fortinet, Inc. |
Ticker | NASDAQ: FTNT |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | July 29, 2026 — After Market Close |
Prepared Date | July 28, 2026 |
Sector ETF Benchmark | BUG (Global X Cybersecurity ETF) |
Key Takeaway: Setup skews to beat — consensus is a manageable bar after Q1’s exceptional outperformance, and channel checks (TD Cowen raised billings estimate to $2.23B vs. guidance midpoint of $2.14B) suggest Q2 is tracking ahead; the single biggest swing factor is whether product revenue sustains its AI data-center-driven momentum or shows any deceleration that would reignite pull-forward concerns.
Heading into Q2 2026, Fortinet’s setup is constructively bullish: consensus billings of ~$2.14B implies ~20% YoY growth, squarely in line with the guidance midpoint management provided on the Q1 call, leaving room for the company to beat as it has done in each of the last eight quarters. Management’s tone on the Q1 call was notably confident — they raised full-year guidance across all top-line metrics, explicitly called out a record Q2 pipeline, and characterized AI data-center demand as a multi-quarter structural cycle rather than a one-time event. Estimate revisions have been modestly positive since the Q1 print, with TD Cowen’s channel-check-driven raise (billings to $2.23B, product revenue to $675M) suggesting the street may still be underestimating product strength. The stock has surged ~67% since the Q1 earnings date (May 6), meaningfully outperforming BUG (+34%) and the S&P 500 (+1%), pricing in a high-quality business re-rating; at ~52x EV/FY27 FCF (TD Cowen’s new multiple), the stock is not cheap, meaning any miss or guidance cut would be punished severely. The key wildcard is service revenue trajectory: consensus expects ~$1.25B in Q2 service revenue, and any sign that the H2 2026 inflection thesis is on track — or at risk — will be the dominant narrative on the call.
Key Takeaway: Consensus is a manageable bar — billings guidance midpoint of $2.14B is essentially in line with current consensus ($2.14B), leaving room for upside if AI data-center demand continues. Product revenue is the bigger swing factor: Q1 came in at $645M vs. ~$534M consensus; a repeat of that magnitude of beat would be the single biggest driver of a positive stock reaction.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance (Midpoint) | Consensus vs. Guidance (%) |
Total Billings ($M) | $2,085 | $1,778 | $2,142 | +20.5% | $2,140 | +0.1% |
Total Revenue ($M) | $1,850 | $1,630 | $1,888 | +15.8% | $1,880 | +0.4% |
Product Revenue ($M) | $645 | $509 | $639 | +25.5% | N/A (implied) | N/A |
Service Revenue ($M) | $1,205 | $1,121 | $1,249 | +11.4% | N/A (implied) | N/A |
Service Billings ($M) | $1,440 | $1,270 | $1,503 | +18.4% | N/A (implied) | N/A |
Unified SASE Billings ($M) | $522 | $425 | $529 | +24.5% | N/A | N/A |
SecOps Billings ($M) | $195 | $197 | $190 | -3.6% | N/A | N/A |
Non-GAAP Operating Income ($M) | $662 | $540 | $643 | +19.1% | ~$627M (34% margin mid) | +2.6% |
Non-GAAP Diluted EPS ($) | $0.82 | $0.64 | $0.75 | +17.2% | $0.72–$0.76 | -1.3% |
Free Cash Flow ($M) | $1,007 | $284 | $538 | +89.4% | N/A | N/A |
Source: Visible Alpha consensus and actuals. Q2 2026 guidance midpoints from Q1 2026 earnings call (May 6, 2026). YoY change calculated vs. Q2 2025 actuals. FCF is highly seasonal (Q1 is typically the strongest quarter). SecOps billings consensus reflects modest YoY decline as the segment laps a strong Q2 2025 comparable.
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q2 2024 | $1,541 | $1,518 | +1.5% | Beat |
Q3 2024 | $1,582 | $1,570 | +0.8% | Beat |
Q4 2024 | $2,003 | $1,956 | +2.4% | Beat |
Q1 2025 | $1,597 | $1,556 | +2.6% | Beat |
Q2 2025 | $1,778 | $1,733 | +2.6% | Beat |
Q3 2025 | $1,808 | $1,809 | -0.1% | In-Line |
Q4 2025 | $2,370 | $2,239 | +5.9% | Beat |
Q1 2026 | $2,085 | $1,799 | +15.9% | Large Beat |
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q2 2024 | $0.57 | $0.41 | +39.0% | Large Beat |
Q3 2024 | $0.63 | $0.52 | +21.1% | Large Beat |
Q4 2024 | $0.74 | $0.61 | +21.3% | Large Beat |
Q1 2025 | $0.58 | $0.54 | +8.0% | Beat |
Q2 2025 | $0.64 | $0.59 | +8.5% | Beat |
Q3 2025 | $0.74 | $0.63 | +17.5% | Large Beat |
Q4 2025 | $0.81 | $0.74 | +9.5% | Beat |
Q1 2026 | $0.82 | $0.62 | +32.3% | Large Beat |
Pattern: FTNT has beaten billings consensus in 7 of the last 8 quarters (one in-line in Q3 2025), with the beat magnitude accelerating sharply in Q4 2025 and Q1 2026 driven by AI data-center demand. EPS has beaten in all 8 quarters, with large beats in 6 of 8 — the consistent EPS outperformance reflects both revenue upside and operating leverage. The bar for Q2 2026 is set at the guidance midpoint, which historically has been a floor rather than a ceiling.
Key Takeaway: Guidance has not been formally revised since the Q1 2026 earnings call (May 6, 2026), but management’s tone has grown more confident — TD Cowen’s channel checks (July 2026) indicate Q2 is tracking ahead of targets, and the Accelerate Investor Briefing (March 2026) reinforced the H2 service revenue inflection thesis. No 8-K guidance update has been filed.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 6, 2026) | Revised Guidance | Current Consensus | Note |
Q2 2026 Billings | $2.09B – $2.19B (mid: $2.14B; +20% YoY) | — | $2.142B | No formal revision; TD Cowen channel checks (Jul 2026) suggest tracking to $2.23B |
Q2 2026 Revenue | $1.83B – $1.93B (mid: $1.88B; +15% YoY) | — | $1.888B | Consensus at midpoint; TD Cowen raised to $1.937B |
Q2 2026 Non-GAAP EPS | $0.72 – $0.76 (mid: $0.74) | — | $0.747 | Consensus at midpoint; upside likely if product revenue beats |
Q2 2026 Non-GAAP Gross Margin | 79.5% – 80.5% | — | ~80% (implied) | Tariff/supply chain pricing actions may pressure product gross margin slightly |
Q2 2026 Non-GAAP Operating Margin | 33% – 35% (mid: 34%) | — | ~34% | Unchanged; management committed to Rule of 45 framework |
FY 2026 Billings | $8.8B – $9.1B (mid: $8.95B; +18% YoY) | — | $8.942B | Consensus near midpoint; TD Cowen raised FY estimate to ~$9.1B |
FY 2026 Revenue | $7.71B – $7.87B (mid: $7.79B; +15% YoY) | — | $7.804B | Consensus slightly above midpoint; TD Cowen at $7.854B (~1% above consensus) |
FY 2026 Service Revenue | $5.09B – $5.15B (mid: $5.12B; +12% YoY) | — | $5.124B | H2 2026 inflection thesis intact; management raised low end of range on Q1 call |
FY 2026 Non-GAAP EPS | $3.10 – $3.16 (mid: $3.13) | — | $3.156 | Consensus at high end of guidance range; upside if Q2 product revenue beats again |
Key Takeaway: Estimates have moved modestly higher since the Q1 2026 print — billings and EPS revisions are tracking with or slightly above guidance, reflecting growing confidence in the AI demand cycle. The gap between current consensus and guidance midpoints is narrow, suggesting the street is not pricing in a large beat, which leaves room for positive surprise.
KPI (Period) | Estimate (May 11, 2026 — 5 Days Post Q1 Print) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Total Billings — Q2 2026 | $2,139M | $2,142M | +0.1% | $2,090M–$2,190M (mid: $2,140M) | Unchanged | — | +0.1% |
Total Revenue — Q2 2026 | $1,886M | $1,888M | +0.1% | $1,830M–$1,930M (mid: $1,880M) | Unchanged | — | +0.4% |
Non-GAAP EPS — Q2 2026 | $0.745 | $0.747 | +0.3% | $0.72–$0.76 (mid: $0.74) | Unchanged | — | +0.9% |
Total Billings — FY 2026 | $8,937M | $8,942M | +0.1% | $8,800M–$9,100M (mid: $8,950M) | Unchanged | — | -0.1% |
Total Revenue — FY 2026 | $7,802M | $7,804M | +0.0% | $7,710M–$7,870M (mid: $7,790M) | Unchanged | — | +0.2% |
Non-GAAP EPS — FY 2026 | $3.149 | $3.156 | +0.2% | $3.10–$3.16 (mid: $3.13) | Unchanged | — | +0.8% |
Product Revenue — Q2 2026 | $637M | $639M | +0.3% | N/A (no explicit guidance) | N/A | — | N/A |
Service Revenue — Q2 2026 | $1,249M | $1,249M | 0.0% | N/A (no explicit guidance) | N/A | — | N/A |
Source: Visible Alpha consensus. Baseline date (May 11, 2026) is 5 trading days after Q1 2026 earnings (May 6, 2026). Estimates have been remarkably stable since the Q1 print, with virtually no revision in either direction — the street is essentially anchored to guidance midpoints. This stability, combined with TD Cowen’s channel-check-driven raise, suggests the risk is skewed to the upside on billings and product revenue.
Key Takeaway: FTNT has surged +66.7% since the Q1 2026 earnings date (May 6, 2026), dramatically outperforming BUG (+34.1%) and the S&P 500 (+1.0%) — the move is driven by a combination of estimate revisions (modest) and a significant multiple re-rating as the market repriced FTNT’s AI data-center exposure and structural SASE opportunity. At current levels (~$150), the stock is pricing in continued execution; any guidance miss would be punished severely given the valuation expansion.
FTNT vs. BUG (Global X Cybersecurity ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings Date (May 6, 2026). Source: Yahoo Finance.
Key Events Since Q1 Earnings:
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for FTNT — PANW’s blowout firewall and SASE results, CRWD’s accelerating ARR growth, and CSCO’s strong double-digit firewall order growth all validate the AI-driven security demand cycle that drove FTNT’s Q1 beat. The key nuance: ZS’s sales leadership disruption is a company-specific negative, not a market signal, and ZS’s own investor day commentary reinforces the structural Zero Trust tailwind. The Mythos AI threat narrative is a multi-quarter structural tailwind for the entire sector.
Read-Through Signal: STRONGLY POSITIVE
Read-Through Signal: MIXED — Market Positive, Company-Specific Negative
Read-Through Signal: POSITIVE (Structural Demand Validation)
Read-Through Signal: POSITIVE (Demand Environment)
Read-Through Signal: POSITIVE (Firewall & Network Security Demand)
Key Takeaway: The most important development since Q1 earnings is TD Cowen’s July 13 channel-check-driven price target raise to $215, which signals Q2 is tracking meaningfully ahead of guidance midpoints — this is the single most actionable pre-print data point. The broader Mythos AI threat narrative has become a sector-wide re-rating catalyst.
Key Takeaway: No open-market buys or discretionary sells from senior executives — all activity is routine 10b5-1 plan sales (CFO) and RSU vesting/conversions (directors and executives). The absence of any discretionary selling by CEO Ken Xie or CTO Michael Xie is notable given the stock’s ~67% rally since Q1 earnings; their silence is a mild positive signal.
Name | Title | Transaction Type | Shares | Date | Note |
Ohlgart, Christiane | Chief Financial Officer | 10b5-1 Planned Sale | 756 shares | May 7, 2026 | Pre-scheduled 10b5-1 plan; routine, not discretionary |
Ohlgart, Christiane | Chief Financial Officer | 10b5-1 Planned Sale | 238 shares | May 11, 2026 | Pre-scheduled 10b5-1 plan; routine, not discretionary |
Ohlgart, Christiane | Chief Financial Officer | 10b5-1 Planned Sale | 756 shares | May 14, 2026 | Pre-scheduled 10b5-1 plan; routine, not discretionary |
Ohlgart, Christiane | Chief Financial Officer | 10b5-1 Planned Sale | 238 shares | May 20, 2026 | Pre-scheduled 10b5-1 plan; routine, not discretionary |
Xie, Michael | VP Engineering & CTO, Director | RSU Vesting / Trust Transfer | 5,854,588 shares | May 19, 2026 | Transfer to trust (indirect ownership); 10b5-1 plan; not an open-market sale |
Whittle, John | Chief Operating Officer | RSU Vesting (Acquisition) | 146,015 shares | May 21, 2026 | RSU vesting; 10b5-1 plan; not an open-market purchase |
Xie, Ken | President & CEO, Director | RSU Vesting (Acquisition) | 155,000 shares | June 2, 2026 | RSU vesting; 10b5-1 plan; not an open-market purchase |
Xie, Michael | VP Engineering & CTO, Director | 10b5-1 Planned Sale | 3,907 shares | June 3, 2026 | Pre-scheduled 10b5-1 plan; small relative to holdings (~10M shares) |
Xie, Michael | VP Engineering & CTO, Director | Gift / Trust Transfer | 5,250 shares | June 4, 2026 | Gift to spouse and self (indirect); 10b5-1 plan; not an open-market sale |
Multiple Directors (Goldman, Hsieh, Hu, Napolitano, Sim, Stavridis) | Board of Directors | RSU Vesting (Conversion) | 650 shares each | June 11, 2026 | Routine annual RSU vesting for all directors; not open-market sales |
Summary: All insider activity since Q1 earnings is either routine 10b5-1 planned sales (CFO Ohlgart, small and consistent), RSU vestings (CEO Ken Xie, CTO Michael Xie, COO Whittle), or director RSU conversions. There are no open-market discretionary sells from any senior executive, and no open-market buys. The absence of discretionary selling by the Xie brothers (who collectively hold tens of millions of shares) despite the stock’s ~67% rally is a mild positive signal — they are not rushing to monetize at current prices. Source: SEC Form 4 filings.